Amneal Pharmaceuticals, Inc. (AMRX) Covered Calls

You can sell covered calls on Amneal Pharmaceuticals, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AMRX (prices last updated Fri 4:16 PM ET):

Amneal Pharmaceuticals, Inc. (AMRX) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
9.59	+0.06	9.52	9.59	1.6M	-	4.4

Covered Calls For Amneal Pharmaceuticals, Inc. (AMRX)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Sep 19	10	0.10	9.49	1.1%	13.8%
Oct 17	10	0.00	9.59	0.0%	0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

Amneal Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and distributes generic pharmaceutical products for various dosage forms and therapeutic areas. It operates through Generic and Specialty Pharma divisions. The company's generics portfolio includes approximately 200 product families marketed in various dosage forms, such as solid oral doses comprising tablets, capsules, and powders; liquids; sterile injectables; nasal sprays; inhalation and respiratory products; ophthalmics; films; transdermal patches; and topicals, as well as soft gel, complex molecule, and drug-device combinations. It is also involved in the development, manufacture, and sale of branded pharmaceutical products primarily for central nervous system disorders and parasitic infections; and biosimilar products. In addition, the company offers licensed and owned, niche, and mature branded products, as well as a pipeline of 505(b)(2) products for various therapeutic areas that primarily includes Unithroid for endocrinologists and primary care physicians through a contracted salesforce. Amneal Pharmaceuticals, Inc. has a partnership agreement with MabXience S.L. for the development of Avastin, a biosimilar bevacizumab. The company has operations in North America, Asia, and Europe. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey

Top 10 Open Interest For Sep 19 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	SLV covered calls	1.	ATYR covered calls
2.	PCG covered calls	7.	FXI covered calls	2.	DNTH covered calls
3.	SPY covered calls	8.	QQQ covered calls	3.	MBX covered calls
4.	IWM covered calls	9.	IBIT covered calls	4.	KSS covered calls
5.	EEM covered calls	10.	INTC covered calls	5.	GTLB covered calls

Want more examples? AMRN Covered Calls | AMSC Covered Calls